drugset / Trial / NCT00153673
Effect of Selective COX-2 Inhibition on Ulcer Healing
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the effect of Famotidine plus a COX-2 inhibitor (celecoxib) with Famotidine plus dologesics in ulcer healing in arthritis patients.
Timeline
- Start
- 2001-02
- Primary completion
- 2016-12-28
- Completion
- 2017-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Celecoxib | Other / unclassified | 200 mg | — |
| Comparator | Dologesics | Unknown | 2 unknown | — |